Illumina Dec 16, 2025 Cell Free DNA Testing Market Is Going to Boom |• Illumina • Guardant Health - openPR.com
Illumina Dec 15, 2025 Illumina (NASDAQ:ILMN) Given New $130.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Illumina Dec 15, 2025 Twists, tangles, and transcription: Does epigenetics play a role in Alzheimer's? - Illumina
Illumina Dec 15, 2025 Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat
Illumina Dec 14, 2025 Illumina’s AI Genomics Partnership With MyOme Might Change The Case For Investing In Illumina (ILMN) - simplywall.st
Illumina Dec 14, 2025 Nikko Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina Dec 11, 2025 Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Illumina Dec 11, 2025 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - marketscreener.com
Illumina Dec 11, 2025 Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina Dec 11, 2025 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire
Illumina Dec 10, 2025 Stifel reiterates Buy rating on Illumina stock, cites multiple growth levers - Investing.com UK
Illumina Dec 9, 2025 Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)? - Yahoo Finance
Illumina Dec 9, 2025 Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance